CIAM
COGT icon

Caitong International Asset Management’s Cogent Biosciences COGT Stock Holding History

Caitong International Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$929 Sell
24
-7,342
-100% -$257K ﹤0.01% 1565
2026
Q1 		$284K Buy
7,366
+5,630
+324% +$208K 0.05% 303
2025
Q4 		$61.7K Buy
1,736
+1,692
+3,845% +$47.6K 0.02% 625
2025
Q3 		$632 Sell
44
-419
-90% -$4.96K ﹤0.01% 1527
2025
Q2 		$3.32K Buy
463
+137
+42% +$759 ﹤0.01% 1193
2025
Q1 		$1.95K Buy
326
+284
+676% +$2.23K ﹤0.01% 1357
2024
Q4 		$328 Buy
+42
New +$419 ﹤0.01% 1525

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Caitong International Asset Management's COGT Position: Q2 2026 in Review

Caitong International Asset Management reduced its Cogent Biosciences (COGT) stake by 100% in Q2 2026, selling an estimated $257K and leaving 24 shares worth $929. The position accounts for ﹤0.01% of the portfolio, ranked #1565.

Caitong International Asset Management first reported a position in COGT in Q4 2024 and has held it in 7 quarters since. The position peaked at $284K in Q1 2026. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Caitong International Asset Management held 24 shares of Cogent Biosciences worth $929 as of Q2 2026.
  • Caitong International Asset Management sold 7,342 Cogent Biosciences shares in Q2 2026, an estimated $257K.
  • Cogent Biosciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1565 holding.
  • Caitong International Asset Management first reported a position in Cogent Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Caitong International Asset Management's Cogent Biosciences position peaked at $284K in Q1 2026.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.